These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 38901207)

  • 41. Application and Development of Cell Membrane Functionalized Biomimetic Nanoparticles in the Treatment of Acute Ischemic Stroke.
    Li Y; Wu C; Yang R; Tang J; Li Z; Yi X; Fan Z
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The potential of biomimetic nanoparticles for tumor-targeted drug delivery.
    Li B; Wang F; Gui L; He Q; Yao Y; Chen H
    Nanomedicine (Lond); 2018 Aug; 13(16):2099-2118. PubMed ID: 30226404
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
    Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
    Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell-derived biomimetic nanocarriers for targeted cancer therapy: cell membranes and extracellular vesicles.
    Li A; Zhao Y; Li Y; Jiang L; Gu Y; Liu J
    Drug Deliv; 2021 Dec; 28(1):1237-1255. PubMed ID: 34142930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biomimetic cell-derived nanocarriers in cancer research.
    Soprano E; Polo E; Pelaz B; Del Pino P
    J Nanobiotechnology; 2022 Dec; 20(1):538. PubMed ID: 36544135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment.
    Wu Y; Wan S; Yang S; Hu H; Zhang C; Lai J; Zhou J; Chen W; Tang X; Luo J; Zhou X; Yu L; Wang L; Wu A; Fan Q; Wu J
    J Nanobiotechnology; 2022 Dec; 20(1):542. PubMed ID: 36575429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.
    Zhai Y; Su J; Ran W; Zhang P; Yin Q; Zhang Z; Yu H; Li Y
    Theranostics; 2017; 7(10):2575-2592. PubMed ID: 28819448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells.
    Zhang L; Deng S; Zhang Y; Peng Q; Li H; Wang P; Fu X; Lei X; Qin A; Yu X
    Adv Healthc Mater; 2020 May; 9(9):e1900772. PubMed ID: 32181988
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biomimetic nanoarchitecturing: A disguised attack on cancer cells.
    Jha A; Nikam AN; Kulkarni S; Mutalik SP; Pandey A; Hegde M; Rao BSS; Mutalik S
    J Control Release; 2021 Jan; 329():413-433. PubMed ID: 33301837
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Enhanced photothermal therapy of biomimetic polypyrrole nanoparticles through improving blood flow perfusion.
    Wang X; Li H; Liu X; Tian Y; Guo H; Jiang T; Luo Z; Jin K; Kuai X; Liu Y; Pang Z; Yang W; Shen S
    Biomaterials; 2017 Oct; 143():130-141. PubMed ID: 28800434
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A RBC membrane-camouflaged biomimetic nanoplatform for enhanced chemo-photothermal therapy of cervical cancer.
    Luo L; Zeng F; Xie J; Fan J; Xiao S; Wang Z; Xie H; Liu B
    J Mater Chem B; 2020 May; 8(18):4080-4092. PubMed ID: 32239064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Homotypic Membrane-Camouflaged Biomimetic Nanoplatform with Gold Nanocrystals for Synergistic Photothermal/Starvation/Immunotherapy.
    Li Z; Rong L
    ACS Appl Mater Interfaces; 2021 May; 13(20):23469-23480. PubMed ID: 33999610
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell Membrane Coated Nanoparticles: An Emerging Biomimetic Nanoplatform for Targeted Bioimaging and Therapy.
    Vijayan V; Uthaman S; Park IK
    Adv Exp Med Biol; 2018; 1064():45-59. PubMed ID: 30471025
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A Review of Biomimetic Nanoparticle Drug Delivery Systems Based on Cell Membranes.
    Zhang M; Du Y; Wang S; Chen B
    Drug Des Devel Ther; 2020; 14():5495-5503. PubMed ID: 33363358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell membrane camouflaged bismuth nanoparticles for targeted photothermal therapy of homotypic tumors.
    Ren X; Yang S; Yu N; Sharjeel A; Jiang Q; Macharia DK; Yan H; Lu C; Geng P; Chen Z
    J Colloid Interface Sci; 2021 Jun; 591():229-238. PubMed ID: 33609894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sorafenib and triptolide loaded cancer cell-platelet hybrid membrane-camouflaged liquid crystalline lipid nanoparticles for the treatment of hepatocellular carcinoma.
    Li Z; Yang G; Han L; Wang R; Gong C; Yuan Y
    J Nanobiotechnology; 2021 Nov; 19(1):360. PubMed ID: 34749742
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recent advances in erythrocyte membrane-camouflaged nanoparticles for the delivery of anti-cancer therapeutics.
    Wang S; Wang Y; Jin K; Zhang B; Peng S; Nayak AK; Pang Z
    Expert Opin Drug Deliv; 2022 Aug; 19(8):965-984. PubMed ID: 35917435
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing.
    He H; Guo C; Wang J; Korzun WJ; Wang XY; Ghosh S; Yang H
    Nano Lett; 2018 Oct; 18(10):6164-6174. PubMed ID: 30207473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Biomimetic Nanotheranostics Camouflaged with Cancer Cell Membranes Integrating Persistent Oxygen Supply and Homotypic Targeting for Hypoxic Tumor Elimination.
    Chen H; Zheng D; Pan W; Li X; Lv B; Gu W; Machuki JO; Chen J; Liang W; Qin K; Greven J; Hildebrand F; Yu Z; Zhang X; Guo K
    ACS Appl Mater Interfaces; 2021 May; 13(17):19710-19725. PubMed ID: 33890760
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iron gallic acid biomimetic nanoparticles for targeted magnetic resonance imaging.
    Chen Y; Zhang Z; Chen Z; Jiang S; Reheman A; Ouyang Y; Yu B; Chen Q; Wei D
    PLoS One; 2024; 19(7):e0306142. PubMed ID: 38954698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.